Atsushi Ono

Serum HMGB1 concentrations at 4 weeks is a useful predictor of extreme poor prognosis for advanced hepatocellular carcinoma treated with sorafenib and hepatic arterial infusion chemotherapy

M. Imamura, K. Chayama, D. Miki, 2017, Journal of Gastroenterology.

Serial profiling of circulating tumor DNA for optimization of anti‐VEGF chemotherapy in metastatic colorectal cancer patients

K. Chayama, D. Miki, Y. Urabe, 2018, International journal of cancer.

Risk factors for histological progression of nonalcoholic steatohepatitis analyzed from repeated biopsy cases.

M. Imamura, K. Chayama, D. Miki, 2020, Journal of gastroenterology and hepatology.

Classification of primary liver cancer with immunosuppression mechanisms and correlation with genomic alterations

S. Miyano, S. Imoto, R. Yamaguchi, 2020, EBioMedicine.

Development of hepatocellular carcinoma in patients with hepatitis C virus infection who achieved sustained virological response following interferon therapy: A large‐scale, long‐term cohort study

M. Imamura, K. Chayama, D. Miki, 2016, Journal of gastroenterology and hepatology.

Involvement of Porphyromonas gingivalis in the progression of non-alcoholic fatty liver disease

M. Imamura, N. Hiraga, K. Chayama, 2018, Journal of Gastroenterology.